Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Colman

Showing results (111-120 of 155) with videos related to

Pageof 16
Sort By:
Journal for Immunotherapy of Cancer|July 3, 2021
Systematic review of combinations of targeted or immunotherapy in advanced solid tumorsAaron C Tan, Stephen J Bagley, Patrick Y Wen, et al.
JCO Precision Oncology|September 11, 2020
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With GlioblastomaBrian M Alexander, Lorenzo Trippa, Sarah Gaffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastomaChristopher E Pelloski, Karla V Ballman, Alfred F Furth, et al.
Cells|December 17, 2024
Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential and the Likelihood of Response to ImmunotherapyIslam Eljilany, Sam Coleman, Aik Choon Tan, et al.
Archives of Pathology & Laboratory Medicine|February 17, 2022
Molecular Biomarker Testing for the Diagnosis of Diffuse GliomasDaniel J Brat, Kenneth Aldape, Julia A Bridge, et al.
Neuro-Oncology Advances|December 30, 2024
Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastomaJoe S Mendez, Adam L Cohen, Midori Eckenstein, et al.
NPJ Precision Oncology|May 22, 2026
Molecular features unique to circulating tumor DNA enable the tumor-naïve liquid biopsy of glioblastomaHunter R Underhill, Drew L Sellers, Sabine Hellwig, et al.
Future Oncology (London, England)|March 28, 2023
Caregiver survey in glioblastoma focused on cognitive dysfunction: development and results from a multicenter studyTrang H Au, Connor Willis, Maija Reblin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent GlioblastomaLakshmi Nayak, Annette M Molinaro, Katherine Peters, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesisChang-Soo Seong, Chunzi Huang, Austin C Boese, et al.
Pageof 16

Showing results (111-120 of 155) with videos related to

Sort By:
Pageof 16
Journal for Immunotherapy of Cancer|July 3, 2021
Systematic review of combinations of targeted or immunotherapy in advanced solid tumorsAaron C Tan, Stephen J Bagley, Patrick Y Wen, et al.
JCO Precision Oncology|September 11, 2020
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With GlioblastomaBrian M Alexander, Lorenzo Trippa, Sarah Gaffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastomaChristopher E Pelloski, Karla V Ballman, Alfred F Furth, et al.
Cells|December 17, 2024
Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential and the Likelihood of Response to ImmunotherapyIslam Eljilany, Sam Coleman, Aik Choon Tan, et al.
Archives of Pathology & Laboratory Medicine|February 17, 2022
Molecular Biomarker Testing for the Diagnosis of Diffuse GliomasDaniel J Brat, Kenneth Aldape, Julia A Bridge, et al.
Neuro-Oncology Advances|December 30, 2024
Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastomaJoe S Mendez, Adam L Cohen, Midori Eckenstein, et al.
NPJ Precision Oncology|May 22, 2026
Molecular features unique to circulating tumor DNA enable the tumor-naïve liquid biopsy of glioblastomaHunter R Underhill, Drew L Sellers, Sabine Hellwig, et al.
Future Oncology (London, England)|March 28, 2023
Caregiver survey in glioblastoma focused on cognitive dysfunction: development and results from a multicenter studyTrang H Au, Connor Willis, Maija Reblin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent GlioblastomaLakshmi Nayak, Annette M Molinaro, Katherine Peters, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesisChang-Soo Seong, Chunzi Huang, Austin C Boese, et al.
Pageof 16